Home » Topics » Regulatory » Patents

Patents
RSS

Hanmi Science patents oncolytic compounds

Aug. 21, 2018

Antiangiogenic compounds synthesized at Celgene

Aug. 21, 2018

Adare Pharmaceuticals describes cysteamine prodrugs

Aug. 21, 2018

Biogen identifies new NRF2 activators

Aug. 21, 2018

Lilly discovers N-Acetyl-beta-D-glucosaminidase inhibitors

Aug. 20, 2018

New lysine-specific histone demethylase 1A inhibitors identified at Medshine Discovery

Aug. 20, 2018

Biogen patents nuclear factor erythroid 2-related factor 2 activators

Aug. 20, 2018

Sumitomo Dainippon Pharma divulges dopamine D1/D2 and/or 5-HT2A receptor antagonists

Aug. 20, 2018

Principia Biopharma patents proteasome subunit beta type-8/beta type-9 inhibitors

Aug. 17, 2018

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical describe TLR7 agonists

Aug. 16, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026